Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy

Mehta R, Shah A, Almhanna K

OncoTargets and Therapy 2018, 11:6525-6537

Published Date: 4 October 2018